Evidence map›Paper›PMID 29054289›Full record

ReviewProgress in brain research2017

Cross-talk between the epigenome and neural circuits in drug addiction.

Philipp Mews, Erin S Calipari

Abstract readReview
In one paragraph

Review in Progress in brain research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. An optimized procedure for robust volitional cocaine intake in mice.Experimental and clinical psychopharmacology · 2021
    Article
  13. From Circuits to Chromatin: The Emerging Role of Epigenetics in Mental Health.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Review
  14. Review
  15. Article
  16. Chromatin Regulation in Complex Brain Disorders.Current opinion in behavioral sciences · 2019
    Article
  17. Epigenetic Priming in Drug Addiction.Cold Spring Harbor symposia on quantitative biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Philipp MewsFriedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Erin S CalipariVanderbilt Center for Addiction Research, Vanderbilt University School of Medicine, Nashville, TN, United States. Electronic address: erin.calipari@gmail.com.
Icahn School of Medicine at Mount Sinai · USVanderbilt University · US

Funding

Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingR00DA042111 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2018 to 2020
$747k
Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingK99DA042111 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CALIPARI, ERIN · 2016 to 2017
$301k
NIDA NIH HHS K99 DA042111NIDA NIH HHS R00 DA042111
6 · The paper itself

Abstract

Drug addiction is a behavioral disorder characterized by dysregulated learning about drugs and associated cues that result in compulsive drug seeking and relapse. Learning about drug rewards and predictive cues is a complex process controlled by a computational network of neural connections interacting with transcriptional and molecular mechanisms within each cell to precisely guide behavior. The interplay between rapid, temporally specific neuronal activation, and longer-term changes in transcription is of critical importance in the expression of appropriate, or in the case of drug addiction, inappropriate behaviors. Thus, these factors and their interactions must be considered together, especially in the context of treatment. Understanding the complex interplay between epigenetic gene regulation and circuit connectivity will allow us to formulate novel therapies to normalize maladaptive reward behaviors, with a goal of modulating addictive behaviors, while leaving natural reward-associated behavior unaffected.

Indexed as

AnimalsBehavior, AddictiveBrainEpigenesis, GeneticEpigenomicsHumansNeural PathwaysSubstance-Related DisordersAddictionCircuitsDopamineEpigeneticsReinforcement

Identifiers

PMID29054289
PMCPMC6339819
OpenAlexW2759198044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.